Prevalence of HTLV-I-associated T-cell lymphoma

American Journal of Hematology

Volumn 66, Issue 1, 2001, Pages 32-38

  Poiesz, B J ^a,o   Papsidero, L D ^b   Ehrlich, G ^a   Sherman, M ^a   Dube, S ^a   Poiesz, M ^a   Dillon, K ^c   Ruscetti, F W ^d   Slamon, D ^e   Fang, C ^f   Williams, A ^f   Duggan, D ^a   Glaser, J ^g   Gottlieb, A ^a   Goldberg, J ^a   Ratner, L ^h   Phillips, P ^a   Han, T ⁱ   Friedman Kien, A ^j   Siegal, F ^k   Rai, K ^k   Sawitsky, A ^k   Sheremata, L W A ^l   Dosik, H ^m   Cunningham, C ^a   Montagna, R ⁿ   more..

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Cellular Products Inc   (United States)

^c Hyland Therapeutics Division   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HOLLAND LABORATORY   (United States)

^g Richmond Memorial Hospital   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

^j NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^k LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m INTERFAITH MEDICAL CENTER   (United States)

ⁿ Innovative Biotechnologies Inc   (United States)

^o State University of New York Upstate Medical University: College of Medicine   (United States)

more..

Author keywords

Blood donors; Human T cell leukemia lymphoma; Needle stick victims; Non Hodgkin's lymphoma; Recipients of blood products; Virus types I and II

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; MALE; NEEDLESTICK INJURY; NONHODGKIN LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RETROVIRUS INFECTION; SEXUAL TRANSMISSION; T CELL LYMPHOMA;

AFRICAN AMERICANS; AGAMMAGLOBULINEMIA; BLOOD DONORS; BLOOD TRANSFUSION; COMORBIDITY; DNA, NEOPLASM; DNA, VIRAL; FAMILY HEALTH; HEMOPHILIA A; HIV INFECTIONS; HIV-1; HIV-2; HTLV-I INFECTIONS; HTLV-II INFECTIONS; INDIANS, NORTH AMERICAN; LEUKEMIA; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LYMPHOMA; LYMPHOMA, AIDS-RELATED; NEEDLESTICK INJURIES; PREVALENCE; RETROVIRIDAE INFECTIONS; RHEUMATIC DISEASES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; THROMBOCYTOSIS; UNITED STATES;

EID: 0035178531     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200101)66:1<32::AID-AJH1004>3.0.CO;2-3     Document Type: Article

References (32)

1. Etiology of acute leukemia, molecular genetics and viral oncology
2. Efficient transformation of previously activated and dividing T lymphocytes by human T-cell leukemia/lymphoma virus
3. Human T-cell leukemia virus type II transforms normal human lymphocytes
4. + lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: A clinical and molecular analysis
5. In vivo cellular tropism of human T-cell leukemia virus type II (HTLV-II)
6. + cells
7. Clonal expansion of human T-cell leukemia virus type-Ia infected cells in asymptomatic and symptomatic carriers with malignancy
8. Expansion of clonotypic T-cell populations in the peripheral blood of asymptomatic Gran Chaco Amerindians infected with HTLV-IIB
9. + T cells from a patient with 'atypical' hairy cell leukemia. Evidence for distinct T and B cell lymphoproliferation disorders
10. Detection of human T-cell leukemia/lymphoma virus type II in a patient with LGL leukemia
11. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection
12. + cutaneous T-cell lymphoma in an HIV-1 infected patient
13. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
14. Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals
15. Segregation of human T cell lymphotropic virus type I and type II infections by antibody reactivity to unique viral epitopes
16. Serological confirmation of human T-lymphotropic virus type 1 infection in healthy blood and plasma donors
17. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses
18. Virally induced T cell malignances and associated diseases
19. Large granular lymphocytosis terminating in a polymorphous B-lymphocytic proliferation after low-dose cyclophosphamide therapy: A case report with necropsy findings
20. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II
21. Guidelines for Counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II)
22. Transmission of human T-lymphotropic virus types I and II by blood transfusion: A retrospective study of recipients of blood components (1983 through 1988)
23. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Center for Disease Control and Prevention Needlestick Surveillance Group
24. Infection with human T-cell leukemia virus type I in patients with leukemia
25. Clinical spectrum of HTLV-I in South Florida
26. HTLV-I induced lymphoma mimicking Hodgkin's disease: Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA
27. Autonomous and interleukin-2-responsive growth of leukemic cells in adult T-cell leukemia (ATL): A review of the clinical significance and molecular basis of ATL cell growth
28. HTLV-I trans-activator protein, tax, is a trans-repressor of the human β-polymerase gene
29. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein
30. HTLV-II risk factors in Native Americans in Florida
31. The complete genomic sequence of an HTLV-II isolate from a Guahibo Indian from Venezuela